Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells.

International journal of immunopathology and pharmacology - 1 Jan 2000

Mu L J, Lazarova P, Gaudernack G, Saeboe-Larssen S, Kvalheim G

Abstract excerpt

Enriched CD34(+) peripheral blood progenitor cells (PBPC) are frequently used as stem cell support in cancer patients following high dose therapy. Since precursor dendritic cells (DCs) originate from haematopoietic progenitor cells, purified CD34(+) cells might also serve as starting cells for ex- vivo production of DC. In the present study we developed a clinical grade procedure for ex- vivo production of DC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Cell Separation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cryopreservation

Share to Culture Media

Share to Dendritic Cells

Share to Growth Substances

Share to Monocytes

Share to Stem Cell Transplantation

Source

Identifiers

PMID: 15461859
DOI: 10.1177/039463200401700305

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells.PMID 15461859Read ↗

Clinical-scale generation of dendritic cells in a closed system.Semantic proximity Read ↗

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.Semantic proximity Read ↗

Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.Semantic proximity Read ↗

Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.Semantic proximity Read ↗

Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.Semantic proximity Read ↗

Phenotypical and functional characterization of clinical grade dendritic cells.Semantic proximity Read ↗

CD34 Splice Variant: An Attractive Marker for Selection of Gene-Modified CellsSemantic proximity Read ↗

Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors.Semantic proximity Read ↗

Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.Semantic proximity Read ↗

Comparison of CD34 and monocyte-derived dendritic cells from mobilized peripheral blood from cancer patients.Semantic proximity Read ↗

CMRF44+ dendritic cells from peripheral blood stem cell harvests of patients with myeloma as potential cellular vectors for idiotype vaccination.Semantic proximity Read ↗

Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.